Sutro Biopharma Inc. (STRO) Prices 11M Share Common Offering at $7.75/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
- BofA raises hyperscaler AI capex outlook to $3.6tn through 2028
After-Hours Stock Movers 05/11: (CBAY) (YRCW) (NVAX) Higher; (GNFT) (STRO) (EB) Lower (more...)
May 11, 2020 5:53 PM EDTToday's After-Hours Stock Movers:
CymaBay Therapeutics (CBAY) 119% HIGHER; independent expert panel unanimously concludes there is no clinical, biochemical or histological evidence of seladelpar-induced liver injury in Phase 2b NASH study.
GENFIT (Nasdaq: GNFT) 50.7% LOWER; announced results from an interim analysis of the RESOLVE-IT Phase 3 trial evaluating once-daily, 120mg of elafibranor in adults with non-alcoholic steatohepatitis (NASH). The trial did not meet the predefined primary endpoint of NASH resolution without worsening of fibrosis in the ITT population of 1,070 patients. The response rate in... More
Sutro Biopharma Inc. (STRO) Announces Proposed Public Offering of Common Stock
May 11, 2020 4:32 PM EDTSutro Biopharma, Inc. (Nasdaq: STRO), a clinical stage drug discovery, development and manufacturing company focused on deploying its proprietary integrated cell-free protein synthesis platform, XpressCF®, to create a broad variety of optimally designed, next-generation protein therapeutics initially for cancer and autoimmune disorders, today announced a proposed underwritten public... More
